Matsukawa H, Okabe E, Sakamoto H, Cho Y W, Ito H
Jpn Circ J. 1978 Apr;42(4):425-32. doi: 10.1253/jcj.42.425.
A beta-adrenergic blocking activity of perhexiline was compared with that of propanolol. In the Langendorff's preparation of rabbits, canine heart-lung preparations, open-chest dog preparations and hind-limbs of dogs, perhexiline failed to block isoproterenol-induced changes in cardiovascular functions, which were effectively blocked by propranolol. These data suggest that perhexiline is not a beta-adrenergic receptor blocking agent.
将哌克昔林的β-肾上腺素能阻断活性与普萘洛尔的进行了比较。在兔的Langendorff制备、犬心肺制备、开胸犬制备以及犬的后肢实验中,哌克昔林未能阻断异丙肾上腺素引起的心血管功能变化,而普萘洛尔可有效阻断这些变化。这些数据表明哌克昔林不是一种β-肾上腺素能受体阻断剂。